Patent ID: 6719992
Filing Date: 2004-04-13
Classification: A61K

Abstract:
A composition of matter, comprising:a) somatotropin; b) a first bioavailability enhancing constituent (BEC); and, c) optionally, a second BEC; wherein the first BEC is a non-ionic surfactant; wherein the second BEC is selected from one or a mixture of two or more of the following: one or more non-reducing carbohydrate(s) and one or more oxo-acid salt(s); wherein the somatotropin and BEC are suspended in a substantially non-aqueous hydrophobic carrier; wherein the somatotropin is present at from about 10% to about 50% by weight of the composition; wherein the first (BEC) is present at from about 0.1% to about 10% by weight of the composition; and, wherein the composition is fluidly injectable at 25Â° C.